Options: Show MedDRA Preferred Terms
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Blood glucose decreased | x | x | x | x | x | x | x | ||||||||||||||
Coma | x | ||||||||||||||||||||
Diabetes mellitus | x | x | x | ||||||||||||||||||
Diabetic | x | ||||||||||||||||||||
Diabetic ketoacidosis | x | x | |||||||||||||||||||
Hyperglycaemia | x | x | x | x | x | x | x | ||||||||||||||
Hypoglycaemia | x | ||||||||||||||||||||
Nephropathy | x | ||||||||||||||||||||
Neuropathy | x | ||||||||||||||||||||
Obesity | x | ||||||||||||||||||||
Retinal disorder | x | ||||||||||||||||||||
Type 1 diabetes mellitus | x | x | |||||||||||||||||||
Type 2 diabetes mellitus | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||
Weight decreased | x | x | x | x | x | x | x | x | x | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |